mFOLFOXIRI
Sponsors
Khon Kaen University, First Affiliated Hospital of Zhejiang University, Dominik Paul Modest, First Affiliated Hospital of Wenzhou Medical University, Yanhong Deng
Conditions
CholangiocarcinomaColo-rectal CancerColon CancerColon CarcinomaColorectal CancerLocally Advanced Rectal CancerMetastatic Colorectal Cancer
Phase 2
Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma
NCT03603834
Start: 2018-09-19End: 2023-12-31Target: 25Updated: 2021-09-01
Neoadjuvant mFOLFOXIRI Chemotherapy Alone for Extramural Vascular Invasion Positive Locally Advanced Rectal Cancer
NCT04170530
Start: 2019-01-01End: 2022-01-01Target: 51Updated: 2019-11-20
A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC
NCT04423965
Start: 2020-05-12End: 2025-05-01Target: 220Updated: 2021-03-23
mFOLFOXIRI Compared to mFOLFOX6 or CapeOx as Adjuvant Chemotherapy for Stage IIIB or IIIC Colorectal Cancer
NCT05200299
Start: 2022-02-01End: 2025-06-30Target: 100Updated: 2022-01-20
Neoadjuvant Treatment With mFOLFOXIRI Plus Cadonilimab (AK104) Versus mFOLFOX6 in Locally Advanced Colorectal Cancer
RecruitingNCT05571644
Start: 2023-07-10End: 2027-08-15Target: 143Updated: 2025-07-23
Study of 5-fluorouracil (5-FU) in Patients With Metastatic Colorectal Cancer
WithdrawnNCT06501989
Start: 2025-09-19End: 2025-09-19Updated: 2026-02-11
Phase 3
Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418)
RecruitingNCT05008809
Start: 2021-12-06End: 2030-11-30Target: 507Updated: 2025-12-12
Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)
Not yet recruitingNCT05427669
Start: 2022-10-09End: 2027-07-01Target: 340Updated: 2022-10-07
Pre-Operative Treatment in REseCTable COlon CanceR
Not yet recruitingNCT06899477
Start: 2025-04-30End: 2035-04-30Target: 714Updated: 2025-03-28